|
|
Suppliers for
1-(beta-D-Xylofuranosyl)uracil
|
|
3 Registered suppliers
Description : 1-(b-D-Xylofuranosyl)uracil, a potent nucleoside analogue, has proven efficacy in treating herpes simplex virus infections as an antiviral agent. Its active mechanism, closely resembling that of natural nucleosides, gives it the ability to impair viral replication, making it a promising therapeutic option for herpes simplex infections. - Molecular Weight :244.20
- Melting Point :158-158.5°C
- Purity :≥95%
Molecular Formula : C9H12N2O6 Canonical SMILES : C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O InChI : InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6+,7-,8-/m1/s1 InChIKey : DRTQHJPVMGBUCF-PXBUCIJWSA-N Solubility : Soluble in Ethanol Appearance : Powder Storage : Store at -20°C Synonyms : 1-beta-D-Xylofuranosyluracil; 1-((2R,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; Xylo-uridine; 1-(beta-D-Xylofuranosyl)uracil; 2,4(1H,3H)-Pyrimidinedione, 1-β-D-xylofuranosyl-
More details are to be found here
|
|
|
Privileged suppliers
Last update 2024-06-10
|